Celsion (CLSN) Tops Q2 EPS by 4c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/3/2026

1. AAPL
2. PLTR
3. VRTX
4. CHKP
5. CRWD
6. ON
7. DOX
8. INSP
9. HNGE
10. AMD

Go back to Celsion (CLSN) Tops Q2 EPS by 4c

Celsion Corporation Reports Second Quarter 2015 Financial Results and Provides Business Update

August 10, 2015 8:00 AM EDT

LAWRENCEVILLE, N.J., Aug. 10, 2015 /PRNewswire/ -- Celsion Corporation (NASDAQ: CLSN), an oncology drug development company, today announced financial results for the quarter ended June 30, 2015 and provided an update on its development programs, including ThermoDox®, its proprietary heat-activated liposomal encapsulation of doxorubicin, and GEN-1, an IL-12 DNA-based immunotherapy encased in a synthetic nanoparticle delivery system, which is currently under development for the localized treatment of ovarian and brain cancers. 

"Over the past few months, we reported positive data highlighting the multiple development opportunities for our portfolio, launched our European Early... More